ZHONGZE THERAPEUTICS
ZHONGZE Therapeutics is a clinical stage biotech company focused on the discovery, development and commercialization of innovative and transformative therapies for both psychiatric and neurological disorders.
ZHONGZE THERAPEUTICS
Industry:
Biotechnology
Founded:
2021-07-23
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.zhongzetherapeutics.com
Status:
Active
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF SSL By Default Mobile Non Scaleable Content Microsoft Azure DNS PHP PHP 7 DigiCert SSL Encryption Everywhere
Similar Organizations
Aurum Healthcare
Aurum Healthcare is a clinical-stage biotechnology company.
Tychan
Tychan is a clinical-stage biotechnology company.
Investors List
CQY Capital
CQY Capital investment in Seed Round - Zhongze Therapeutics
Cenova
Cenova investment in Seed Round - Zhongze Therapeutics
Official Site Inspections
http://www.zhongzetherapeutics.com
- Host name: 47.116.20.86
- IP address: 47.116.20.86
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Zhongze Therapeutics"
Zhongze Therapeutics - Crunchbase Company Profile …
ZHONGZE Therapeutics is a clinical stage biotech company focused on the discovery, development and commercialization of innovative and …See details»
Zhongze Therapeutics Company Profile 2024: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Zhongze Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Shanghai Zhongze Pharmaceutical Technology Co., Ltd
Explore Shanghai Zhongze Pharmaceutical Technology Co., Ltd with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, Disease Domain:Nervous ...See details»
Zhongze Therapeutics Announces Successful Completion Of The …
Apr 1, 2022 /PRNewswire/ -- Zhongze Therapeutics, a clinical stage biotech company focused on the discovery, development and commercialization of innovative and...See details»
Zhongze Announces Collaboration with Fudan Prof. Nashat …
Mar 8, 2022 Prof. Nashat Abumaria has previously found that the TRPM7 ion channel plays an important role in synaptic and cognitive functions as well as in Alzheimer's disease. Zhongze …See details»
About Zhongze
ZHONGZE Therapeutics is a clinical-stage biotech company dedicated to the research, development, and commercialization of innovative treatments for Psychiatric Disorders.Our …See details»
上海中泽医药科技有限公司_投融资最新情况_摩熵医药 (原药融云)
上海中泽医药是一家临床阶段创新药物研发公司，专注于通过自主研发和产品引进相结合的模式开发针对中枢神经系统（CNS）疾病的优质创新药物，致力于开发出可以改变病程进展的CNS …See details»
Shanghai Zhongze Pharmaceutical Technology Co., Ltd
May 7, 2025 了解Shanghai Zhongze Pharmaceutical Technology Co., Ltd (上海中泽医药科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的5项临床试验, 4篇新闻，疾病领域: …See details»
上海中泽医药 - 公司详情 - 公司图谱 - innoHere英诺嘿呀
上海中泽医药科技有限公司成立于2017-09-08，注册地址为中国（上海）自由贸易试验区蔡伦路781号1101室，法定代表人为马万军，经营范围包括一般项目：从事医药科技领域内的技术开 …See details»
Zhongze Therapeutics - VentureRadar
ZHONGZE Therapeutics is a clinical stage biotech company focused on the discovery, development and commercialization of innovative and transformative therapies for both …See details»
Zhongze Therapeutics Announces Successful Completion Of The …
SHANGHAI, April 1, 2022 /PRNewswire/ -- Zhongze Therapeutics, a clinical stage biotech company focused on the discovery, development and commercialization of innovative and …See details»
zhongzetherapeutics.com - 上海中泽医药
上海中泽医药企业门户网站聚焦精神性疾病创新药研发 Focusing on the research, development and commercialization of innovative agents for Psychiatric DisorderSee details»
Zhongze Therapeutics | VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
中泽医药-动脉网 - vbdata.cn
Sep 8, 2017 中泽医药是一个面向世界的临床阶段创新药物研发公司。公司专注于通过自主研发和产品引进相结合的模式开发针对CNS疾病的优质创新药物。我们基于神经可塑性假说，拥有表 …See details»
About Us - zhongzetherapeutics.com
ZHONGZE Therapeutics is a clinical stage company committed to discovering innovative medicines that will contribute to a world without suffering from schizophrenia.See details»
NEWS - zhongzetherapeutics.com
Zhongze Therapeutics Announces Successful Completion Of The First-In-Human Dose Escalation Study of ZZ6398 in Healthy Volunteers SHANGHAI, CHINA, April. 1, 2022– …See details»
ZHONGZE Completed Series Pre-A Round Financing of 10 million …
Recently, ZHONGZE Therapeutics has completed a Series Pre-A round financing of 10 million dollars. The fund will be used for the development of ZHONGZE's innovative CNS product …See details»
Digestome Therapeutics Announces Exclusive Out-license of DGX …
Feb 25, 2022 DGX-001 is a first-in-class oral therapeutic being initially developed for the treatment of negative symptoms and cognitive impairment in patients with schizophrenia, and …See details»
上海中泽医药 - 公司详情 - 公司概况 - innoHere英诺嘿呀
上海中泽医药是一家临床阶段创新药物研发公司，专注于通过自主研发和产品引进相结合的模式开发针对中枢神经系统（CNS）疾病的优质创新药物，致力于开发出可以改变病程进展的CNS …See details»